Sildenafil is usually a powerful and selective inhibitor of cGMP-certain phosphodiesterase type five (PDE5), which happens to be responsible for degradation of cGMP from the corpus cavernosum. The molecular composition of sildenafil is comparable to that of cGMP and acts like a competitive binding agent of PDE5 in the corpus cavernosum, leading to